CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Cholesterol-Lowering Agents A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients Association Between Living in Food Deserts and Cardiovascular Risk Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial Advances in Coronary No-Reflow Phenomenon-a Contemporary Review Translational Perspective on Epigenetics in Cardiovascular Disease

Review Article2019 Feb;124(3):364-385.

JOURNAL:Circ Res. Article Link

Cholesterol-Lowering Agents

Rosenson RS, Hegele RA, Koenig W. Keywords: cardiovascular disease; cholesterol; myocardial infarction; patients; subtilisin

FULL TEXT PDF